Vitaspring Biomedical Co. Ltd.
VSBC OTC
SEC CIK 1697884
Follow Vitaspring Biomedical Co. Ltd.
Weekly email: filings, results
Revenue, last quarter
$0
Net income
−$155.8K
−40.6% vs same quarter last year
EPS, diluted
$0.00
Operating cash flow
$5.2K
+538.4% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY26 | $0 | −$415.4K |
| FY25 | $0 | −$774.9K |
| FY24 | $0 | −$1.1M |
| FY23 | $0 | −$4.2M |
| FY22 | $5.6M | $909.6K |
| FY21 | $248.2K | $425.4K |
| FY20 | $15.1K | $6.9K |
| FY19 | $17.2K | −$22.4K |
| FY18 | $16.2K | −$6.4K |
| FY17 | $0 | −$45 |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY26 | - | - | - |
| FY25 | - | - | - |
| FY24 | - | - | - |
| FY23 | - | - | - |
| FY22 | 36.8% | 20.1% | 16.2% |
| FY21 | 45.2% | 171.4% | 171.4% |
| FY20 | 11.2% | 45.7% | 45.7% |
| FY19 | 79.8% | −130.4% | −130.4% |
| FY18 | 69.9% | −39.3% | −39.3% |
| FY17 | - | - | - |
- Vitaspring Biomedical Co. Ltd.
- Healthcare median
Show the numbers
| Year | Vitaspring Biomedical Co. Ltd. | Healthcare median |
|---|---|---|
| FY26 | - | −11.1% |
| FY25 | - | −30.6% |
| FY24 | - | −47% |
| FY23 | - | −58% |
| FY22 | 16.2% | −80.4% |
| FY21 | 171.4% | −71.9% |
| FY20 | 45.7% | −62.2% |
| FY19 | −130.4% | −46.3% |
| FY18 | −39.3% | −49.6% |
| FY17 | - | −45.9% |